These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 3180046)
1. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells. Scher BM; Scher W; Waxman S Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046 [TBL] [Abstract][Full Text] [Related]
2. DNA ligase and DNase activities in mouse erythroleukemia cells during dimethyl sulfoxide-induced differentiation. Scher BM; Scher W; Robinson A; Waxman S Cancer Res; 1982 Apr; 42(4):1300-6. PubMed ID: 6949637 [TBL] [Abstract][Full Text] [Related]
3. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide. Waxman S; Scher BM; Hellinger N; Scher W Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439 [TBL] [Abstract][Full Text] [Related]
4. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells. Lo SC; Aft R; Mueller GC Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076 [TBL] [Abstract][Full Text] [Related]
5. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents. Gascoyne PR; Becker FF J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526 [TBL] [Abstract][Full Text] [Related]
6. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole. Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412 [TBL] [Abstract][Full Text] [Related]
7. Can glutathione-S-transferases function as intracellular heme carriers? Kirschner-Zilber I; Laufer H; Shaklai N J Cell Biochem; 1989 Nov; 41(3):113-23. PubMed ID: 2613748 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
10. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C. Durkin JP; Chakravarthy B; Tremblay R; Jouishomme H; Whitfield JF; Biquard JM; Krsmanovic V Cancer Res; 1992 Nov; 52(22):6329-34. PubMed ID: 1423278 [TBL] [Abstract][Full Text] [Related]
11. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application. Marks PA; Rifkind RA Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266 [TBL] [Abstract][Full Text] [Related]
12. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells. Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880 [TBL] [Abstract][Full Text] [Related]
13. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities. Aroor AR; Singh LP; Wahba AJ Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531 [TBL] [Abstract][Full Text] [Related]
14. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation. Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709 [TBL] [Abstract][Full Text] [Related]
16. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563 [TBL] [Abstract][Full Text] [Related]
17. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells. Sherman ML; Shafman TD; Kufe DW J Cell Physiol; 1988 Mar; 134(3):429-36. PubMed ID: 2450878 [TBL] [Abstract][Full Text] [Related]
18. The role of heme in the regulation of the late program of Friend cell erythroid differentiation. Mager D; Bernstein A J Cell Physiol; 1979 Sep; 100(3):467-79. PubMed ID: 489671 [TBL] [Abstract][Full Text] [Related]
19. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC. Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]